Citations (96)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Kenneth M Dürsteler, Eva-Maria Berger, Johannes Strasser, Carlo Caflisch, Jochen Mutschler, Marcus Herdener & Marc Vogel. (2015) Clinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence. Substance Abuse and Rehabilitation 6, pages 61-74.
Read now
Read now
James Shearer. (2008) The principles of agonist pharmacotherapy for psychostimulant dependence. Drug and Alcohol Review 27:3, pages 301-308.
Read now
Read now
G. R. A. Focchi, M. C. Leite, A. G. Andrade & S. Scivoletto. (2005) Use of Dopamine Agonist Pergolide in Outpatient Treatment of Cocaine Dependence. Substance Use & Misuse 40:8, pages 1169-1177.
Read now
Read now
EugeneC. Somoza, TheresaM. Winhusen, T.
Peter Bridge, JohnP. Rotrosen, DouglasG. Vanderburg, JudyM. Harrer, JurisP. Mezinskis, MargaretA. Montgomery, DomenicA. Ciraulo, LawsonR. Wulsin & JeraA. Barrett. (2004) An Open-Label Pilot Study of Methylphenidate in the Treatment of Cocaine Dependent Patients with Adult Attention Deficit/ Hyperactivity Disorder. Journal of Addictive Diseases 23:1, pages 77-92.
Read now
Read now
Bruce K. Alexander & Jonathan Y. Tsou. (2001) Prospects for Stimulant Maintenance in Vancouver, Canada. Addiction Research & Theory 9:2, pages 97-132.
Read now
Read now
Beth K Boyarsky & Elinore F. McCance-Katz. (2000) Improving the Quality of Substance Dependency Treatment with Pharmacotherapy. Substance Use & Misuse 35:12-14, pages 2095-2125.
Read now
Read now
Ismene L. Petrakis, Sally L. Satel, Susan Stine, Thomas R. Kosten, Sheila N. Namanworth, Dennis S. Charney & John H. Krystal. (1996) AMPT Effects on Cue-Induced Craving for Cocaine. American Journal on Addictions 5:4, pages 313-320.
Read now
Read now
Frances R. Levin & Herbert D. Kleber. (1995) Attention-Deficit Hyperactivity Disorder and Substance Abuse: Relationships and Implications for Treatment. Harvard Review of Psychiatry 2:5, pages 246-258.
Read now
Read now
Thomas R. Kosten, Marlene Steinberg & Lonas A. Diakogiannis. (1993) Crossover Trial of Mazindol for Cocaine Dependence. American Journal on Addictions 2:2, pages 161-164.
Read now
Read now
Yifrah Kaminer. (1992) Clinical Implications of the Relationship Between Attention-Deficit Hyperactivity Disorder and Psychoactive Substance Use Disorders. American Journal on Addictions 1:3, pages 257-264.
Read now
Read now
Roger D. Weiss & Steven M. Mirin. (1990) Psychological and Pharmacological Treatment Strategies in Cocaine Dependence. Annals of Clinical Psychiatry 2:4, pages 239-243.
Read now
Read now
Joan
Ellen Zweben & DavidE. Smith. (1989) Considerations in Using Psychotropic Medication with Dual Diagnosis Patients in Recovery. Journal of Psychoactive Drugs 21:2, pages 221-228.
Read now
Read now
Irl L. Extein, Sharman Allen, Mark S. Gold, Aldo Morales, Paul J. Goodnick & David A. Gross. (1989) Comparison of Bromocriptine and Desipramine in Cocaine Withdrawal. Annals of Clinical Psychiatry 1:3, pages 193-197.
Read now
Read now
Herbert D. Kleber. (1989) Treatment of Drug Dependence: What Works. International Review of Psychiatry 1:1-2, pages 81-99.
Read now
Read now
Daniel H. Golwyn. (1988) Cocaine Abuse Treated with Phenelzine. International Journal of the Addictions 23:9, pages 897-905.
Read now
Read now
Margaret L Griffin, Roger D. Weiss, Steven M. Mirin, Harvey Wilson & Brigitte Bouchard-Voelk. (1987) The Use of the Diagnostic Interview Schedule in Drug-Dependent Patients. The American Journal of Drug and Alcohol Abuse 13:3, pages 281-291.
Read now
Read now
Herbert Kleber & Frank Gawin. (1986) Psychopharmacological Trials in Cocaine Abuse Treatment. The American Journal of Drug and Alcohol Abuse 12:3, pages 235-246.
Read now
Read now
Articles from other publishers (79)
Letizia Tschudi, Sebastian Karl Maximilian Fischer, Evgeniy Perlov, Markus R. Baumgartner, Michael Soyka, Thomas Jörg Müller, Erich Seifritz & Jochen Mutschler. (2023) Concomitant Drug Use among Opioid-Dependent Patients with and without Attention Deficit Hyperactivity Disorder: Does Methylphenidate Merit a Trial?. European Addiction Research, pages 1-8.
Crossref
Crossref
Vitor S. Tardelli, Lais F. Berro, Gilberto Gerra, Leonardo Tadonio, Adam Bisaga & Thiago M. Fidalgo. (2023) Prescription psychostimulants for cocaine use disorder: A review from molecular basis to clinical approach. Addiction Biology 28:4.
Crossref
Crossref
Stephen G. Davies, Ai M. Fletcher, Matthew E. Peters, Paul M. Roberts & James E. Thomson. (2019) The asymmetric synthesis of (S,S)-methylphenidate hydrochloride via ring-opening of an enantiopure aziridinium intermediate with phenylmagnesium bromide. Tetrahedron 75:49, pages 130713.
Crossref
Crossref
. 2019. Handbook of Crime Correlates. Handbook of Crime Correlates
453
702
.
Scott J. Moeller, Anna B. Konova, Dardo Tomasi, Muhammad A. Parvaz & Rita Z. Goldstein. (2016) Abnormal response to methylphenidate across multiple fMRI procedures in cocaine use disorder: feasibility study. Psychopharmacology 233:13, pages 2559-2569.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
492
542
.
Silvia Minozzi, Laura Amato, Pier Paolo Pani, Renata Solimini, Simona Vecchi, Franco De Crescenzo, Piergiorgio Zuccaro & Marina Davoli. (2015) Dopamine agonists for the treatment of cocaine dependence. Cochrane Database of Systematic Reviews 2015:5.
Crossref
Crossref
Andrew C. McCreary, Christian P. Müller & Małgorzata Filip. 2015. The Neuropsychiatric Complications of Stimulant Abuse. The Neuropsychiatric Complications of Stimulant Abuse
41
83
.
Ariadna Forray & Mehmet Sofuoglu. (2014) Future pharmacological treatments for substance use disorders. British Journal of Clinical Pharmacology 77:2, pages 382-400.
Crossref
Crossref
Laura Amato, Silvia Minozzi, Pier Paolo Pani, Renata Solimini, Simona Vecchi, Piergiorgio Zuccaro & Marina Davoli. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Bernardo Soares, Anelise ARL Lima Reisser, Michael Farrell & Mauricio Silva de Lima. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
David V. Herin, Craig. R. Rush & John Grabowski. (2010) Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Annals of the New York Academy of Sciences 1187:1, pages 76-100.
Crossref
Crossref
Giovanni B. Cassano, Lorenzo Lattanzi, Antonella Litta, Valentina Lombardi, Alessandro Tatulli, Alessandra Benedetti, Antonio Longobardi & Icro Maremmani. (2009) Is Aripiprazole Useful to Refrain From Cocaine Use After Detoxification (Avoiding Relapses)?. Addictive Disorders & Their Treatment 8:4, pages 161-166.
Crossref
Crossref
. 2009. Meyler's Side Effects of Psychiatric Drugs. Meyler's Side Effects of Psychiatric Drugs
451
628
.
Nora D. Volkow, Gene-Jack Wang, Frank Telang, Joanna S. Fowler, Jean Logan, Anna-Rose Childress, Millard Jayne, Yeming Ma & Christopher Wong. (2008) Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues. NeuroImage 39:3, pages 1266-1273.
Crossref
Crossref
Michael J. Kuhar. 2007. Ciba Foundation Symposium 166 - Cocaine: Scientific and Social Dimensions. Ciba Foundation Symposium 166 - Cocaine: Scientific and Social Dimensions
81
95
.
Herbert D. Kleber. 2007. Ciba Foundation Symposium 166 - Cocaine: Scientific and Social Dimensions. Ciba Foundation Symposium 166 - Cocaine: Scientific and Social Dimensions
195
206
.
G. A. Wiesbeck & K. Dürsteler-MacFarland. (2006) Neue Entwicklungen in der Pharmakotherapie der KokainabhängigkeitNew developments in the pharmacotherapy of cocaine dependence. Der Nervenarzt 77:9, pages 1064-1070.
Crossref
Crossref
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions
848
879
.
Jeffrey J. WilsonFrances R. Levin. (2005) Attention-Deficit/Hyperactivity Disorder and Early-Onset Substance Use Disorders. Journal of Child and Adolescent Psychopharmacology 15:5, pages 751-763.
Crossref
Crossref
Mary Jeanne Kreek, Gavin Bart, Charles Lilly, K. Steven Laforge & David A. Nielsen. (2005) Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments. Pharmacological Reviews 57:1, pages 1-26.
Crossref
Crossref
John Grabowski, James Shearer, John Merrill & S. Stevens Negus. (2004) Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addictive Behaviors 29:7, pages 1439-1464.
Crossref
Crossref
Huw M.L. Davies, Darrin W. Hopper, Tore Hansen, Quixu Liu & Steven R. Childers. (2004) Synthesis of methylphenidate analogues and their binding affinities at dopamine and serotonin transport sites. Bioorganic & Medicinal Chemistry Letters 14:7, pages 1799-1802.
Crossref
Crossref
Shelly F Greenfield, Sumita G Manwani & Jessica E Nargiso. (2003) Epidemiology of substance use disorders in women. Obstetrics and Gynecology Clinics of North America 30:3, pages 413-446.
Crossref
Crossref
Bernardo Soares, Anelise ARL Lima Reisser, Michael Farrell & Maurício Silva de Lima. 1996. The Cochrane Database of Systematic Reviews. The Cochrane Database of Systematic Reviews.
Guilherme R de Azevedo Focchi, Marcos da C Leite & Sandra Scivoletto. (2001) Utilização do agonista dopaminérgico pergolida no tratamento da "fissura" por cocaína. Revista Brasileira de Psiquiatria 23:4, pages 188-194.
Crossref
Crossref
Jeffrey J. Wilson & Frances R. Levin. (2001) Attention deficit hyperactivity disorder (ADHD) and substance use disorders. Current Psychiatry Reports 3:6, pages 497-506.
Crossref
Crossref
John Grabowski, Howard Rhoades, Joy Schmitz, Angela Stotts, Lee Ann Daruzska, Dan Creson & F. Gerard Moeller. (2001) Dextroamphetamine for Cocaine-Dependence Treatment: A Double-Blind Randomized Clinical Trial. Journal of Clinical Psychopharmacology 21:5, pages 522-526.
Crossref
Crossref
MARIA A. SULLIVAN & FRANCES RUDNIK-LEVIN. (2006) Attention Deficit/Hyperactivity Disorder and Substance Abuse. Annals of the New York Academy of Sciences 931:1, pages 251-270.
Crossref
Crossref
CHRISTOPHER J. WELSH & JOSEPH LIBERTO. (2001) The Use of Medication for Relapse Prevention in Substance Dependence Disorders. Journal of Psychiatric Practice 7:1, pages 15-31.
Crossref
Crossref
F. R. Levin & H. D. Kleber. 2001. Contemporary Psychiatry. Contemporary Psychiatry
2135
2152
.
John Grabowski, Howard Rhoades, Peter Silverman, Joy M. Schmitz, Angela Stotts, Dan Creson & Rahn Bailey. (2000) Risperidone for the Treatment of Cocaine Dependence: Randomized, Double-Blind Trial. Journal of Clinical Psychopharmacology 20:3, pages 305-310.
Crossref
Crossref
Satendra Singh. (2000) Chemistry, Design, and Structure−Activity Relationship of Cocaine Antagonists. Chemical Reviews 100:3, pages 925-1024.
Crossref
Crossref
John D. Roache, John Grabowski, Joy M. Schmitz, Daniel L. Creson & Howard M. Rhoades. (2000) Laboratory Measures of Methylphenidate Effects in Cocaine-Dependent Patients Receiving Treatment. Journal of Clinical Psychopharmacology 20:1, pages 61-68.
Crossref
Crossref
KEVIN A. SEVARINO, ALISON OLIVETO & THOMAS R. KOSTEN. (2006) Neurobiological Adaptations to Psychostimulants and Opiates as a Basis of Treatment Development. Annals of the New York Academy of Sciences 909:1, pages 51-87.
Crossref
Crossref
Anna Rose Childress & Charles P O’Brien. (2000) Dopamine receptor partial agonists could address the duality of cocaine craving. Trends in Pharmacological Sciences 21:1, pages 6-9.
Crossref
Crossref
F. R. Levin & H. D. Kleber. 2000. Erlebens- und Verhaltensstörungen, Abhängigkeit und Suizid. Erlebens- und Verhaltensstörungen, Abhängigkeit und Suizid
547
577
.
P. Christopher H. Gottschalk, Leslie K. Jacobsen & Thomas R. Kosten. (1999) Current concepts in pharmacotherapy of substance abuse. Current Psychiatry Reports 1:2, pages 172-178.
Crossref
Crossref
Peter Tucker. (2009) Attention‐deficit/hyperactivity disorder in the drug and alcohol clinic. Drug and Alcohol Review 18:3, pages 337-344.
Crossref
Crossref
Gail Winger. 1998. Cocaine Abuse. Cocaine Abuse
135
158
.
S. John Gatley, Andrew N. Gifford, Nora D. Volkow & Joanna S. Fowler. 1998. Handbook of Substance Abuse. Handbook of Substance Abuse
161
185
.
John Grabowski, John D. Roache, Joy M. Schmitz, Howard Rhoades, Daniel Creson & Ania Korszun. (1997) Replacement Medication for Cocaine Dependence. Journal of Clinical Psychopharmacology 17:6, pages 485-488.
Crossref
Crossref
Kyle M. Kampman & Joseph Volpicelli. (1997) Letter to the editor. Journal of Substance Abuse Treatment 14:4, pages 401-402.
Crossref
Crossref
Elizabeth A. Warner, Thomas R. Kosten & Patrick G. O'Connor. (1997) PHARMACOTHERAPY FOR OPIOID AND COCAINE ABUSE. Medical Clinics of North America 81:4, pages 909-925.
Crossref
Crossref
Nick E. Goeders. (1997) A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology 22:4, pages 237-259.
Crossref
Crossref
Jayendra K. Patel, Eileen Wong & Alan I. Green. 1997.
19
29
.
S.John Gatley, Nora D. Volkow, Andrew N. Gifford, Yu-Shin Ding, Jean Logan & Gene-Jack Wang. (1997) Model for estimating dopamine transporter occupancy and subsequent increases in synaptic dopamine using positron emission tomography and carbon-11-labeled cocaine. Biochemical Pharmacology 53:1, pages 43-52.
Crossref
Crossref
Ismene L. Petrakis, Sally L. Satel, Susan Stine, Thomas R. Kosten, Sheila N. Namanworth, Dennis S. Charney & John H. Krystal. (2010) AMPT Effects on Cue‐Induced Craving for Cocaine. The American Journal on Addictions 5:4, pages 313-320.
Crossref
Crossref
S John Gatley, Susanne M. Meehan, Ruoyan Chen, Dong-Feng Pan, Martin D. Schechter & Stephen L. Dewey. (1996) Place preference and microdialysis studies with two derivatives of methylphenidate. Life Sciences 58:24, pages PL345-PL352.
Crossref
Crossref
Jack H. Mendelson & Nancy K. Mello. (1996) Management of Cocaine Abuse and Dependence. New England Journal of Medicine 334:15, pages 965-972.
Crossref
Crossref
S John Gatley, Dongfeng Pan, Ruoyan Chen, Gaurav Chaturvedi & Yu-Shin Ding. (1996) Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sciences 58:12, pages PL231-PL239.
Crossref
Crossref
M. J. Kuhar & C. R. Schuster. 1996. Pharmacological Aspects of Drug Dependence. Pharmacological Aspects of Drug Dependence
53
80
.
E. A. Wallace & T. R. Kosten. 1996. Pharmacological Aspects of Drug Dependence. Pharmacological Aspects of Drug Dependence
627
644
.
A. Smith, D. C. S. Roberts & M. Piercey. (1995) Effect of (−)-DS 121 and (+)-UH 232 on cocaine self-administration in rats. Psychopharmacology 120:1, pages 93-98.
Crossref
Crossref
James W. Cornish, Iraj Maany, Paul J. Fudala, Sheryl Neal, Sabrina A. Poole, Patricia Volpicelli & Charles P. O'Brien. (1995) Carbamazepine treatment for cocaine dependence. Drug and Alcohol Dependence 38:3, pages 221-227.
Crossref
Crossref
Nancy W. Withers, Luigi Pulvirenti, George F. Koob & J. Christian Gillin. (1995) Cocaine Abuse and Dependence. Journal of Clinical Psychopharmacology 15:1, pages 63-78.
Crossref
Crossref
Jeffrey M. Witkin. (1994) Pharmacotherapy of cocaine abuse: Preclinical development. Neuroscience & Biobehavioral Reviews 18:1, pages 121-142.
Crossref
Crossref
Thomas R. Kosten, Marlene Steinberg & Ionas A. Diakogiannis. (2010) Crossover Trial of Mazindol for Cocaine Dependence. The American Journal on Addictions 2:2, pages 161-164.
Crossref
Crossref
Kathleen M. Carroll & Bruce J. Rounsaville. (1993) History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Comprehensive Psychiatry 34:2, pages 75-82.
Crossref
Crossref
John Strang, Andrew Johns & Woody Caan. (2018) Cocaine in the UK-1991. British Journal of Psychiatry 162:1, pages 1-13.
Crossref
Crossref
Neal L. Benowitz. (2009) Clinical Pharmacology and Toxicology of Cocaine. Pharmacology & Toxicology 72:1, pages 3-12.
Crossref
Crossref
Mark S. Kleven & William L. Woolverton. (1993) Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys. Drug and Alcohol Dependence 31:2, pages 149-158.
Crossref
Crossref
John Strang, Michael Farrell & Sujata Unnithan. 1993. Cocaine and Crack. Cocaine and Crack
146
172
.
Yifrah Kaminer. (2010) Clinical Implications of the Relationship Between Attention‐Deficit Hyperactivity Disorder and Psychoactive Substance Use Disorders. The American Journal on Addictions 1:3, pages 257-264.
Crossref
Crossref
YIFRAH KAMINER. (1992) Desipramine Facilitation of Cocaine Abstinence in an Adolescent. Journal of the American Academy of Child & Adolescent Psychiatry 31:2, pages 312-317.
Crossref
Crossref
ROGER D. WEISS, STEVEN M. MIRIN & MARGARET L. GRIFFIN. (2010) Methodological considerations in the diagnosis of coexisting psychiatric disorders in substance abusers. British Journal of Addiction 87:2, pages 179-187.
Crossref
Crossref
Mary C. Ritz, Michael J. Kuhar & Frank R. George. 1992. Recent Developments in Alcoholism. Recent Developments in Alcoholism
273
302
.
Sylvia Lacombe, Steven W. Stanislav & Patricia A. Marken. (2016) Pharmacologic Treatment of Cocaine Abuse. DICP 25:7-8, pages 818-823.
Crossref
Crossref
M.J. Kuhar, M.C. Ritz & J.W. Boja. (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends in Neurosciences 14:7, pages 299-302.
Crossref
Crossref
Steven M. Mirin, Roger D. Weiss, Margaret L. Griffin & Jacqueline L. Michael. (1991) Psychopathology in drug abusers and their families. Comprehensive Psychiatry 32:1, pages 36-51.
Crossref
Crossref
Murray E. Jarvik. (1990) The Drug Dilemma: Manipulating the Demand. Science 250:4979, pages 387-392.
Crossref
Crossref
Steven E. Krug. (1989) Cocaine abuse: Historical, epidemiological, and clinical perspectives for pediatricians. Current Problems in Pediatrics 19:9, pages 451-487.
Crossref
Crossref
Roger D. Weiss, Margaret L. Griffin & Steven M. Mirin. (1989) Diagnosing major depression in cocaine abusers: The use of depression rating scales. Psychiatry Research 28:3, pages 335-343.
Crossref
Crossref
Mark H. Pollack, Andrew W. Brotman & Jerrold F. Rosenbaum. (1989) Cocaine abuse and treatment. Comprehensive Psychiatry 30:1, pages 31-44.
Crossref
Crossref
Frank H. Gawin & Everett H. EllinwoodJr.Jr.. (1988) Cocaine and Other Stimulants. New England Journal of Medicine 318:18, pages 1173-1182.
Crossref
Crossref
John Wallace. (1988) The relevance to clinical care of recent research in neurobiology. Journal of Substance Abuse Treatment 5:4, pages 207-217.
Crossref
Crossref
John B. Murray. (2016) Psychophysiological Effects of Methylphenidate (Ritalin). Psychological Reports 61:1, pages 315-336.
Crossref
Crossref
Thomas J. Young. (2016) Illicit Cocaine Use in Clinical Perspective. International Journal of Offender Therapy and Comparative Criminology 31:2, pages 179-187.
Crossref
Crossref
Frank Gawin & Herbert Kleber. (1986) Pharmacologic Treatments of Cocaine Abuse. Psychiatric Clinics of North America 9:3, pages 573-583.
Crossref
Crossref